Rett Syndrome

Trofinetide – Rett syndrome Innovation Trofinetide is a novel synthetic analog of the amino‐terminal tripeptide of IGF-1 designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function. ACADIA has an exclusive license to develop and commercialize trofinetide in North America from Neuren Pharmaceuticals. About Rett syndrome Rett syndrome is a … Continue reading Rett Syndrome